When all the11 eligible studies were pooled into the meta-analysis of MMP-7 -181A>Gpolymorphism, we have not found evidence of a significant MMP-7 -181A>Gpolymorphism with CRC risk under all the five genetic models. This evidence concerns the gene MMP7 and colorectal carcinoma.